Fredun Pharmaceuticals Ltd — Results, 31-05-2025: Result

Fredun Pharmaceuticals has announced a board meeting on which it approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025. The company reported a standalone net profit of Rs. 707.18 lakh for the quarter and Rs. 2,080.76 lakh for the year, with earnings per share of Rs. 14.98 and Rs. 44.83 respectively. Consolidated net profit stood at Rs. 600.35 lakh for the quarter and Rs. 2,046.41 lakh for the year. The Board has proposed a final dividend of 7% per share, subject to shareholder approval. The Group expanded by incorporating Fredun Retail Private Limited and acquiring One Pet Stop Private Limited during the year. The statutory auditors issued unmodified opinions on the financials. However, the company has delayed transferring unclaimed dividends and related shares from FY 2015-16 and 2016-17 to the Investor Education and Protection Fund.